doxepin has been researched along with Smoking Cessation in 2 studies
Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
Smoking Cessation: Discontinuing the habit of SMOKING.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Various dosage forms of nicotine replacement therapy increase smoking quit rates relative to placebo, but they generally do not result in 1-year quit rates of over 20%." | 2.41 | Effect of nonnicotine pharmacotherapy on smoking behavior. ( Golding, M; Hatsukami, DK; Jamerson, BD; Kotlyar, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kotlyar, M | 1 |
| Golding, M | 1 |
| Hatsukami, DK | 1 |
| Jamerson, BD | 1 |
| Sachs, DP | 1 |
| Leischow, SJ | 1 |
2 reviews available for doxepin and Smoking Cessation
| Article | Year |
|---|---|
Effect of nonnicotine pharmacotherapy on smoking behavior.
Topics: Amphetamines; Bupropion; Clonidine; Doxepin; Humans; Naltrexone; Nortriptyline; Selective Serotonin | 2001 |
Pharmacologic approaches to smoking cessation.
Topics: Clonidine; Doxepin; Humans; Nicotine; Smoking; Smoking Cessation; Weight Gain | 1991 |